PegBio Co., Ltd. Class H · OTC:PGBIF

PegBio Co., Ltd. Class H financial statements

PegBio Co., Ltd. Class H's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022
Revenue0000
Cost of revenue00
Gross profit00
Research and development50.4M95.4M236.7M280.3M
Selling, general and administrative37.0M192.4M55.4M13.2M
Operating income-205.9M-280.9M-277.5M-318.5M
Depreciation and amortization3.74M2.20M3.44M4.39M
EBITDA-202.2M-278.6M-274.0M-314.1M
Interest expense2.78M6.82M11.6M159.0K
Income before tax-208.5M-283.4M-279.2M-306.3M
Net income-208.4M-283.2M-279.0M-306.4M
Earnings per share, basic-0.53-0.73-0.72-0.79

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents467.5M28.4M77.1M60.3M
Short-term investments54.5M153.7M263.1M333.5M
Inventory873.0K0
Current assets556.3M190.3M345.5M403.9M
Property, plant and equipment5.10M6.95M
Total assets599.2M218.4M368.1M437.5M
Accounts payable25.2M35.1M90.6M94.0M
Current liabilities141.1M157.7M165.0M125.7M
Total liabilities150.6M166.2M178.2M131.8M
Shareholders' equity448.5M52.2M189.9M300.0M
Shares outstanding391.1M386.0M386.0M386.0M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-151.9M-183.4M-233.3M-171.4M
Capital spending-3.66M-1.08M-617.0K-3.21M
Free cash flow-155.6M-184.5M-233.9M-174.6M
Cash from investing114.4M101.6M
Cash from financing20.3M148.5M
Change in cash444.9M-48.8M16.9M-171.4M